Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 3
2005 2
2006 4
2007 4
2008 5
2009 5
2010 6
2011 3
2012 4
2013 4
2014 5
2015 3
2016 2
2017 2
2018 7
2019 6
2020 4
2021 4
2022 5
2023 4
2024 4
2025 4
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Endocrine Therapy.
Shah R, O'Regan RM. Shah R, et al. Among authors: o regan rm. Cancer Treat Res. 2018;173:15-29. doi: 10.1007/978-3-319-70197-4_2. Cancer Treat Res. 2018. PMID: 29349755 Review.
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer.
O'Regan RM, Zhang Y, Fleming GF, Francis PA, Kammler R, Viale G, Dell'Orto P, Lang I, Bellet M, Bonnefoi HR, Tondini C, Villa F, Bernardo A, Ciruelos EM, Neven P, Karlsson P, Müller B, Jochum W, Zaman K, Martino S, Geyer CE Jr, Jerzak KJ, Davidson NE, Coleman RE, Ingle JN, van Mackelenbergh MT, Loi S, Colleoni M, Schnabel CA, Treuner K, Regan MM. O'Regan RM, et al. JAMA Oncol. 2024 Oct 1;10(10):1379-1389. doi: 10.1001/jamaoncol.2024.3044. JAMA Oncol. 2024. PMID: 39145953 Free PMC article. Clinical Trial.
Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer.
Jones V, Yin HH, Yuan YC, Wang Y, Li SM, Aljaber D, Sanchez A, Quinones C, Schmolze D, Yuan Y, Mortimer J, Yee L, Kruper L, Jovanovic-Talisman T, Tomsic J, Sanchez N, Chavez T, O'Regan RM, Khan QJ, Davis M, Kalinsky K, Meisel J, Kittles R, Rodriguez-Rodriguez L, Seewaldt V. Jones V, et al. Among authors: o regan rm. Sci Rep. 2025 Feb 28;15(1):7220. doi: 10.1038/s41598-025-89274-9. Sci Rep. 2025. PMID: 40021703 Free PMC article.
Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index.
O'Regan RM, Ren Y, Zhang Y, Siuliukina N, Schnabel CA, Kammler R, Viale G, Dell'Orto P, Munzone E, Láng I, Tondini C, Gomez HL, Chini C, Nicoletti SVL, Puglisi F, Zaman K, Goetz MP, Stearns V, Martino S, Salim M, Loibl S, Geyer CE, Bonnefoi HR, Ciruelos EM, Loi S, Colleoni M, Fleming GF, Francis PA, Walley BA, Pagani O, Treuner K, Regan MM. O'Regan RM, et al. JAMA Netw Open. 2025 Nov 3;8(11):e2540931. doi: 10.1001/jamanetworkopen.2025.40931. JAMA Netw Open. 2025. PMID: 41182766 Free PMC article.
Optimizing Endocrine Therapy for Breast Cancer.
Zelnak AB, O'Regan RM. Zelnak AB, et al. Among authors: o regan rm. J Natl Compr Canc Netw. 2015 Aug;13(8):e56-64. doi: 10.6004/jnccn.2015.0125. J Natl Compr Canc Netw. 2015. PMID: 26285250 Review.
Race, breast cancer, and prognosis: Where biology is queen?
Meisel JL, O'Regan RM. Meisel JL, et al. Among authors: o regan rm. Cancer. 2019 Sep 15;125(18):3104-3106. doi: 10.1002/cncr.32294. Epub 2019 Jun 17. Cancer. 2019. PMID: 31206611 Free article. No abstract available.
83 results